# Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

> **NCT00478192** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Hyponatremia

## Interventions

- **DRUG:** Conivaptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00478192
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478192, "Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00478192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*